Hepatitis C Seroconversion Remains High among Patients with Regular Hemodialysis: Study of Associated Risk Factors

Table 2

Association of risk factors with HCV infection in hemodialysis patients.

Variable	Anti-HCV (+); ()	Anti-HCV (-); ()	value	Odd ratio	95% CI
Gender
Male	54 (57.0%)	152 (61.9%)	0.413	0.817	0.504-1.326
Female	40 (43.0%)	92 (38.1%)
Age
18-59 yr	65 (69.9%)	186 (74.3%)	0.182	1.431	0.844-2.425
≥60 yr	29 (30.1%)	58 (25.7%)
Duration of HD
<5 yr	72 (76.6%)	157 (64.3%)	0.031	1.164	0.320-0.951
≥5 yr	22 (23.4%)	87 (35.7%)
Vascular access
AV fistula	93 (98.9%)	168 (68.9%)	<0.001	42.071	5.757-307.472
Catheter double lumen	1 (1.1%)	76 (31.1%)
Dialyzer reuse
Yes	82 (87.2%)	110 (45.1%)	<0.001	8.324	4.319-16.044
No	12 (12.8%)	134 (54.9%)
History of transfusion
Yes	39 (41.5%)	112 (45.9%)	0.465	0.836	0.516-1.352
No	55 (58.5%)	132 (54.1%)
History of surgery
Yes	1 (1.1%)	0 (0%)	0.278^a
No	93 (98.9%)	244 (100%)
Diabetes mellitus
Yes	16 (17.0%)	44 (18.0%)	0.827	1.019	0.497-1.749
No	78 (83.0%)	200 (82.0%)
Hepatitis B infection
Yes	1 (1.1%)	9 (3.4%)	0.281	1.256	0.128-2.941
No	93 (98.9%)	235 (96.6%)
Type of HD unit
Hospital	27 (28.7%)	183 (75.0%)	<0.001	0.134	0.079-0.229
Private	67 (71.2%)	61 (25.0%)

cell with value less than 5; Fisher exact test.